Posts filed under: Wound and Tissue Management

  Register to receive a free Europe Market Report Suite for Wound and Tissue Management report synopsis and brochure Australian stem cell and regenerative medicine company Cynata Therapeutics Limited  is pleased to announce that it has received positive data demonstrating the efficacy...
Continue Reading →
Register to receive a free Europe Market Report Suite for Wound and Tissue Management report synopsis and brochure Smith & Nephew released the results from a trial of its Allevyn Life multi-layer silicone adhesive foam dressing, touting that its addition to standard care...
Continue Reading →
Biofilms are clusters of bacteria that, when present in chronic wounds, are linked to delayed healing, and are resistant to antimicrobial treatments....
Continue Reading →
Gecko Biomedical (“Gecko”), a medical device company developing innovative polymers to support tissue reconstruction, announced today that it has received CE Mark approval for its SETALUM™ Sealant allowing the company to market its technology in Europe....
Continue Reading →
Under the terms of the distribution agreement, Terumo Corporation (a leading provider of high quality, innovative medical devices), will have the exclusive rights to market Sylys in Japan....
Continue Reading →
Linking SANUWAVE's dermaPACE® wound treatment device with eKare's inSight® 3D wound imaging and analytics system, the two companies will strive to produce the industry's most comprehensive wound management solution....
Continue Reading →
STRATAFIX™ and DERMABOND® advanced wound closure products are available in one convenient kit through DePuy Synthes...
Continue Reading →
Gawley Plastic Surgery and MD Skin Lounge are excited to offer this new treatment, which offers patients who are experiencing early signs of aging and do not wish to undergo invasive surgery an additional option....
Continue Reading →
Ethicon is releasing two new knotless suture devices for open and minimally invasive surgical applications. The STRATAFIX Spiral PDS Plus is intended for fat, deep tissue and organ work, while the STRATAFIX Spiral Monocryl Plus is targeted at skin and...
Continue Reading →
The combined market for external wound and internal tissue management products in the U.S. is valued at almost $8.1 billion; this market is expected to increase, reaching almost $11 billion by 2022....
Continue Reading →
close-link
close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link
close-link